Skip to content
Insurance, Medical Health Aged Care

Free doctor telehealth consults in cost-of-living measure – Aussie first

October 04, 2024 3 mins read

More than 2.2 million Aussies will have access to several free telehealth consults with doctors, in a private health insurance first, as part of a cost-of-living health measure, aimed at also relieving strains on emergency hospital departments and GPs.

 

Through Bupa’s digital health platform, Blua, eligible Bupa health insurance members will pay zero out of pocket costs for three telehealth bookings per person, per year, as part of their policy. They will have 24/7 access to doctors for consultations that may include general medical advice, repeat prescriptions or referrals.

 

Results from a ten month-long trial of Blua online doctors revealed most calls occurred outside business hours with 72% resolved on the initial call, 15% were recommended to visit a GP in person and only 1% advised to go to a hospital emergency department.

 

Bupa Clinical Director Dr Simon Benson said demand for telehealth services remained popular with patients due to its accessibility and convenience.

 

“This is about making medical care accessible and affordable 24/7 while taking some of the pressure off hospital emergency departments in the afterhours period,” Dr Benson said.

 

“As Australians continue to face cost of living challenges, we’re providing greater value for our customers, with up to three free consultations per person, per year, and ensuring they receive the ‘right care’ in the ‘right place’ at the ‘right time’ by focusing on quality and safety.

 

“Blua telehealth can also play an important role in assisting where patient demand is high and where there are long wait times to see a local GP.”

 

Dr Benson said 91% of telehealth consultations were delivered via video consultations, as many patients still wanted face to face connection with their doctor, while the remainder were telephone consults.

 

Data from the online doctor trial revealed consultations for cough, fever, cold and headache were most common, followed by prescriptions or medical certificates.

 

As part of Blua, many of Bupa’s 4.4 million customers also have access to an online door-to-door chemist delivery service. Since launching earlier this year, most of the orders have been for e-scripts which have free delivery.

 

Dr Benson said Blua online doctors and chemist delivery were about simple, person-centred care.

 

“The pandemic has changed how people want to access their healthcare and we are making sure it fits in with their changing health and wellbeing needs,” he said.

 

“We know GPs play a vital role in Australia’s primary health system and Blua online doctors is designed to support the healthcare system, and not replace family doctor relationships.”

 

Bupa customers will have access to a network of more than 150 Australian-based credentialled doctors through a partnership approach with providers. To ensure continuity of care, patients will have a care summary uploaded to their My Health Record, subject to consent.


The Bupa Pulse Check, an independent survey of more than 2000 Australians, found the top drivers of online care were no need to travel, convenience, more affordable, quicker/less wait times and ease of access.

 

 

Telehealth fast facts:

 

Why people are choosing online healthcare:

  

Don’t need to travel – 39%

Convenience – 38%

Don’t need to wait in a clinic – 36%

Quicker and less time consuming – 33%

Usually just need something small (repeat medication, results) – 30%

Can access from anywhere – 29%

Cheaper – 16%

 

 *Source Bupa Pulse Check 2024

 

Common reasons for consultations: 

  • Migraine
  • Renew prescription
  • Medical certificate
  • Coughing
  • Cold and flu
  • Anxiety
  • Check-up
  • Acne
  • Allergy
  • Back pain
  • Covid
  • Diarrhoea
  • Stomach pain

 

 *Source: Blua telehealth trial data October 2023 – September 2024

 

Outcome of consultation, as indicated by doctor:

  • Resolved – 72%
  • Referred to GP 15%
  • Referred to ED 1%
  • Referred to allied health 1%

Source: Blua telehealth trial data October 2023 – September 2024

 

ENDS

 

Note to News Desks

 

Interviews available with Dr Simon Benson

Case study available for interviews

 

For more information, please contact:

 

Aleks Devic                                                    
Head of Media (Health Insurance) and Content, Bupa                             
Email:
aleks.devic@bupa.com.au     

Mob: 0412 868 933                                                      

 

About Bupa Asia Pacific

Bupa is an international healthcare group which has been committed to a purpose of helping people live longer, healthier, happier lives and making a better world for more than 70 years.

Bupa Asia Pacific operates in Australia, New Zealand and Hong Kong, supporting about 7.3 million customers through a broad range of health and care services including health insurance, aged care, dental, medical, optical and hearing services.

Employing more than 22,000 people in the region, we believe that we can make a real difference to the lives of customers through our values, purpose and the way that we deliver personalised care.

Over the past 17+ years we have invested more than AUD$36 million in partnerships and programs focused on improving health of communities across Australia.



 

 

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.